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INTRODUCTION
The self-paced maximal oxygen uptake ( ·VO2 max) test (SPV), which 
is based upon the Borg 6-20 Ratings of Perceived Exertion (RPE) sca-
le, allows participants to self-regulate their exercise intensity during 
a closed-loop incremental maximal exercise test. Laboratory-based 
SPV protocols have been shown to elicit higher [1-3] or compara-
ble [4-6]  ·VO2max values to those reported from a conventional open-
loop laboratory-based graded exercise test (GXT). Despite these fin-
dings, caution should be exercised with their interpretation as the 
reliability of the SPV protocol has yet to be examined. Enhanced 
reliability implies greater precision of one-off measures and better 
tracking of changes in measurements in research or practical set-
tings [7].
The self-paced nature of exercising in an outdoor environment, 
where an individual is free to vary their pace, cannot be easily rep-
licated in the laboratory environment [8]. The ecological validity of 
laboratory-based running protocols are reduced as the conscious 
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ABSTRACT: The self-paced maximal oxygen uptake (VO2max) test (SPV), which is based on the Borg 6-20 
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There were no differences in the VO2max reported between the GXT (63.5±10.1 ml·kg-1·min-1) and each SPV 
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VO2max values from the SPV, the application of a single SPV test is an appropriate stand-alone protocol for 
gauging VO2max.
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decision to manually control the treadmill belt speed does not occur 
as quickly or as frequently as during self-paced running outside [9,10]. 
As there are small but significant differences between running on a 
track and running on a treadmill due to variation in airstream, ground 
surface and movement patterns [8], the transferability of laboratory 
measurements to training and competitive situations may be limited. 
Accordingly, it is of interest to investigate the efficacy and reproduc-
ibility of the SPV in measuring  ·VO2max and the pace response dur-
ing field-based exercise. Should the SPV prove to be reliable, this 
test may be of practical value to coaches when monitoring and 
prescribing exercise for athletes.
The purpose of this study was to assess the concurrent validity 
and reproducibility of a field-based SPV test in comparison to a con-
ventional GXT. It was hypothesised that the SPV protocol would val-
idly measure  ·VO2max and elicit reproducible findings in relation to 
 ·VO2max and the pacing response across three field-based SPV tests.
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MATERIALS AND METHODS 
Subjects. This was a cross-sectional experimental study wherein 
fifteen men (23.9 ± 4.5 y, 1.74 ± 0.05 m, 73.9 ± 7.5 kg) who 
were recreationally-trained (>3 h·wk-1 of vigorous athletic training) 
participated in the study. Based on effect sizes (dz = 0.88) and mean 
(± SD) statistics for  ·VO2max [1], a minimum sample size of n = 12 
was calculated to achieve a statistical power of 80% at an alpha 
level of .05. Participants were injury free, healthy and asymptom-
atic of any illness as confirmed through health screening procedures 
[11]. All participants had previous experience of undertaking maxi-
mal exercise testing in a laboratory environment, but none had com-
pleted the SPV test. Institutional ethical approval was obtained 
prior to the study in accordance with the spirit of the Helsinki Dec-
laration, and participants provided written informed consent. 
Procedures
Following basic anthropometric measurements, participants com-
pleted a laboratory-based GXT (19.6 ± 1.2 °C, 40.8 ± 5.1% [hu-
midity], 1001.2 ± 8.3 hPa) on a motorised treadmill (True 825, 
Fitness Technologies, St Louis, USA). Subsequently, participants 
completed three field-based SPV exercise tests (SPV1, SPV2, SPV3), 
on an outdoor 400m athletics track at the same time of day (±1h) 
(19.8 ± 3.5 °C, 51.7 ± 13.9% [humidity], 1012.3 ± 6.3 hPa, 
2.9 ± 2.1 km·h-1 [maximum wind speed]). All tests were separated 
by a 72h recovery period in which participants refrained from any 
normal training activities. Respiratory gases (oxygen uptake [  ·VO2], 
ventilation [ ·VE], respiratory exchange ratio [RER]) were continu-
ously measured using a portable breath-by-breath sampling system 
(K4-b-TX Module, Cosmed, Roe, Italy), and a global positioning sys-
tem (GPS) watch (Suunto Ambit, Valimotie, Finland) was used to 
assess heart rate and the pacing response (using 5 s data averages) 
throughout each exercise test. Blood lactate (Lactate Pro, Kyoto, Japan) 
was assessed prior to and 1 min post each exercise test. Participants 
were perceptually anchored to the Borg 6-20 RPE scale [12] and to 
a 0-10 localized-leg-pain scale [13] by definition and recall procedures. 
By definition, participants were instructed that the differing numerical 
values equated to the feelings associated with the corresponding 
written definitions on each scale (e.g., RPE 20 equates to ‘maximal 
exertion’). Anchoring by recall refers to encouraging the participant to 
remember the range of feelings previously experienced during exercise 
of a similar nature (e.g., Pain 10 equates to an extremely intense 
pain). Physiological data (and treadmill speeds during the GXT) were 
masked from participants throughout both exercise tests.
During the GXT, ·VO2max was confirmed by a visible plateau in 
oxygen consumption of ≤ 2 mL·kg-1·min-1 with a standard increment 
in exercise intensity, and / or any secondary criterion indicators (vis-
ible signs of exhaustion; HRmax ± 10 b·min-1; RER ≥ 1.15), at or 
around the point of volitional exhaustion [11]. The ·VO2max value 
determined in the GXT was clarified using a verification stage [14]. 
Given the design and closed-loop nature of the SPV, whereby a non-
linear change in running speed is expected in the final stage of the 
test, the highest measure of ·VO2 was taken as the 
·VO2max, indepen-
dent of changes in running speed.  
Laboratory-based GXT 
Participants initially completed a self-directed warm-up on the tread-
mill (2.5 min at a running speed equivalent to an RPE11; 2.5 min 
at an RPE13). The GXT commenced at the speed which was equiv-
alent to RPE13 from the warm-up; a speed deemed sufficient to 
elicit  ·VO2max within 10 (±2) min [14]. The GXT was continuous 
and incremental, commencing at the chosen speed and increasing 
by 1 km·hr-1 every 2 min thereafter until volitional exhaustion. The 
treadmill gradient was set at 1% to reflect the energy cost associ-
ated with outdoor running [15]. During the final 20 s of each incre-
ment of the GXT, participants reported their overall RPE and localised 
pain perception. Following a 15 min recovery period, participants 
completed a  ·VO2max verification stage whereby speed was gradu-
ally increased over a 30 s period to a speed which was 1 km·hr-1 
higher than the final stage of the GXT. Participants exercised at this 
elevated speed until volitional exhaustion. Respiratory markers were 
monitored throughout. Peak speed at  ·VO2max was the running speed 
at which  ·VO2max occurred, provided that the running time was 
greater than 1 min.
Field-based SPV 
Following a similar warm-up to the GXT, participants commenced 
the SPV. This test was 10 min in duration and comprised five x 2 
min stages of incremental exercise, which were adjusted according 
to prescribed RPE levels, equating to a light (RPE11), somewhat 
hard (RPE13), hard (RPE15), very hard (RPE17) and maximal RPE 
(RPE20). Participants were instructed to modify their running speed 
on a moment-to-moment basis in line with the prescribed RPE, 
rather than the end-point of the task, so that their RPE (not their 
speed) remained clamped for each given 2 min stage. The RPE scale 
was visible at regular intervals (every 100 m). During the final 20 s 
of each increment of the SPV, the researchers would show the exer-
cise-induced pain scale to the participants whilst they were running 
to obtain their current perception of pain.
Following a 15 min recovery period, participants completed a 
 ·VO2max verification stage whereby participants repeated the final 
two, 2 min stages of the SPV test (RPE17 & RPE20). Respiratory 
markers were monitored throughout.
Statistical analysis 
Breath-by-breath data ( ·VO2, VE, RER) from the GXT and SPV tests 
were averaged into 10 s bins and used in the following analyses. To 
assess the concurrent validity and reproducibility of the SPV, one-way 
ANOVAs compared the maximal physiological ( ·VO2max, HRmax, 
etc.), perceptual and physical (peak speed, average speed, distance, 
duration) data reported from the GXT to each SPV test (e.g., GXT vs. 
SPV1), and between each SPV test (e.g., SPV1 vs. SPV2). A Bland 
and Altman 95% limits-of-agreement (LoA) analysis quantified the 
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agreement (bias ± random error [1.96 × SD]) between the  ·VO2max 
reported from the GXT and each of the SPV tests [16]. Intraclass 
correlation coefficients (ICCs) were calculated to quantify the repro-
ducibility of the maximal physiological criteria between the GXT and 
SPV tests, and between each of the SPV tests. A reliability coefficient 
(the smallest detectable difference) was also used to determine the 
critical difference in a parameter that must be exceeded between 
two sequential results in order for a statistically significant change 
to occur in an individual. A one-sample t-test was used to compare 
the maximal RPE from the GXT and SPV (RPE20).
To assess the pacing response during the SPV, two factor repeated 
measures ANOVA’s; Test (SPV1, SPV2, SPV3) by RPE (RPE11, RPE13, 
RPE15, RPE17, RPE20) were used to compare the distance covered, 
and the peak, mean and end running speeds for each SPV test. Where 
significant differences were reported, Tukey’s HSD was used to iden-
tify the location of any statistical differences (between SPV1, SPV & 
SPV3). A similar analysis was conducted to compare the coefficient 
of variation (CV) in running speed between each of the five percep-
tual intensities. The CV was calculated using the following equation:
Whereby,  is the standard deviation of the running speed for a 
given perceptual intensity, and μ is the mean. Two-factor repeated 
measures ANOVAs were also used to assess the physiological re-
sponses ( ·VO2, HR,  
·VE, RER) during the SPV tests. Partial eta squared 
(ηp2) was used to demonstrate the effect size, with .0099, .0588 
and .1379 representing a small, medium and large effect, respec-
tively [17]. Partial eta squared was calculated using the following 
formula:
ηp
2 =       SSEffect
         SSEffect + SSError
Whereby, SSEffect is the estimated variance for a given outcome 
measure, and SSError is the error variance that is attributable to the 
effect. Alpha was set at 0.05 throughout all analyses. All data were 
analysed using the statistical package SPSS for Windows, PC Soft-
ware, version 22.
RESULTS 
As there were no differences between  ·VO2max values reported from 
the GXT and SPV when compared to their corresponding verification 
test, the GXT and SPV data are used in the proceeding analyses. 
GXT SPV1 SPV2 SPV3
VO2max (ml∙kg-1∙min-1) 63.5 ± 10.1 65.5 ± 8.7 65.4 ± 7.0 66.7 ± 7.7
VEmax (L∙min-1) 155 ± 17.2 161 ± 16.9 161 ± 16.5 163 ± 16.0
HRmax (b∙min-1) 192 ± 6.8 191 ± 7.1 190 ± 8.0 191 ± 7.8
Maximal RER 1.00 ± 0.9 1.05 ± 0.1 1.01 ± 0.1 1.00 ± 0.1
Maximal Blood Lactate (mmol∙L-1) 11.7 ± 3.1 11.0 ±2.5 10.3 ± 2.4 10.9 ± 2.0
Maximal Pain 8.4 ± 2.3 8.0 ± 2.5 7.7 ± 2.6 7.6 ± 2.6
Maximal RPE 19.8 ± 0.4 20 ± 0 20 ± 0 20 ± 0
Peak Speed (km·h-1) 17.7 ± 0.9 19.8 ± 2.5 18.9 ± 2.8 19.9 ± 2.9
Average Speed (km·h-1) 13.8 ± 1.0 14.4 ± 1.1* 14.6 ± 1.1* 15.0 ±1.2*
Total Distance (m) 2620 ± 284.6 2389 ± 160* 2425 ± 177 2462 ± 184
Test Duration (sec) 621 ± 43 600 ± 0 600 ± 0 600 ± 0
SPV 1-SPV2 SPV2-SPV3 SPV1, SPV2 & SPV3
Mean Diff 
(±) SD ICC SEM RC
Mean Diff 
(±) SD ICC SEM RC ICC SEM RC
VO2max (ml·kg-1·min-1) 0.05 ± 12.0 0.81 3.15 8.73 -1.31 ± 12.0 0.92 2.07 5.74 0.80 3.16 8.77
VEmax (L·min-1) 0.27 ± 3.6 0.95 3.62 10.03 0.06 ± 3.6 0.97 2.91 8.06 0.94 3.87 10.73
HRmax (b·min-1) 0.7 ± 23.6 0.94 1.87 5.18 -2.4 ± 23.6 0.98 1.12 3.10 0.94 1.88 5.20
Maximal RER 0.5 ± 10.6 0.35 0.04 0.12 -0.3 ± 10.6 0.53 0.04 0.11 0.17 0.03 0.09
Maximal Blood Lactate (mmol·L-1) 0.04 ± 0.12 0.66 1.17 3.25 0.02 ± 0.12 0.68 1.06 2.94 0.56 1.15 3.19
Maximal Pain 0.69 ± 3.6 0.94 0.64 1.77 -0.55 ±3.6 0.99 0.23 0.65 0.94 0.63 1.75
Peak Speed (km·h-1) 0.9 ± 3.4 0.83 1.03 2.85 -0.9 ± 3.4 0.88 0.93 2.56 0.81 1.10 3.04
Average Speed (km·h-1) -0.2 ± 1.6 0.92 0.30 0.84 -0.4 ± 1.6 0.93 0.30 0.83 0.87 0.39 1.08
Total Distance (m) -36 ± 293 0.93 44.7 123.9 -37 ± 293 0.95 38.9 107.7 0.90 54.5 151.1
TABLE 2. Reliability of the physiological, perceptual and physical responses recorded from all SPV tests. Data is presented as the mean 
difference between tests, ICC, SEM and RC.
TABLE 1. Mean (± SD) physiological, perceptual and physical responses recorded at completion of the GXT and SPV tests.
Note: *Significant difference between SPV and GXT (P < 0.001).
Note: ICC, Intraclass correlation coefficients; SEM, Standard error of the mean; RC, Reliability coefficient
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Concurrent validity: GXT vs SPV 1, SPV 2, & SPV 3
There were no differences in the maximal physiological or percep-
tual values reported when comparing the GXT with each of the SPV 
tests (all P > .05; Table 1). Significant differences in average speed 
(F(3,56) = 20.54, P < .001, ηp2 = .60) and total distance (F(3,56) = 
3.601, P < .05, ηp2 = .16) were however observed (Table 1). For 
the  ·VO2max reported from the GXT and SPV1, SPV2 and SPV3, the 
corresponding ICC and 95 % LoA were; 0.85 and 2.01 ± 13.26 
ml · kg-1 · min-1 (GXT vs. SPV1), 0.85 and 1.96 ± 12.28 ml · kg-1 · 
min-1 (GXT vs. SPV2) and 0.87 and 3.27 ± 11.93 ml · kg-1 · min-1 
(GXT vs. SPV3, respectively). 
Reproducibility: SPV1 vs.SPV2 vs SPV3 
There were no differences in the maximal physiological, perceptual 
or physical values reported when comparing the three SPV tests (all 
P > .05; Tables 1 and 2). Although RER and BLa provided low to 
moderate ICCs, all other parameters provided strong ICCs between 
SPV1 and SPV2, SPV2 and SPV3, and between all SPV tests (all ≥ 
0.80).
Pacing response during SPV tests
Figure 1 demonstrates the mean (±SD) pacing strategy at each 
perception of exertion for SPV1-SPV3. There were no Test by RPE 
interactions for the peak speed, mean speed, end speed and for the 
FIG. 1. Pacing response, 5 second averages for SPV 1, SPV 2 and 
SPV 3 at RPE 11, RPE 13, RPE 15, RPE 17 and RPE 20.
FIG. 2. Mean (± SD) peak speed (2a), mean speed (2b), end speed (2c) and distance (2d) reported at RPE 11, 13, 15, 17 and 20 from 
the three SPV tests.
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distance ran from the SPV tests (all P > .05; Figure 2). Similar 
findings were observed when considering the CV for running speed 
(F(3.1,42.7) = 1.44, P > .05, ηp2 = .09; Table 3). An RPE main effect 
was observed for peak (F(1.4,19.1) = 18.06, P < .001, ηp2 = .56), 
mean (F(1.4,19.6) = 26.69, P  < .001, ηp2 = .66) and end speed 
(F(2.1,29.4) = 16.95, P  < .001, ηp2 = .55), and for the distance ran 
(F(2.3,32) = 23.47, P  < .001, ηp2 = .63), with significant increases 
occurring at various increments in exercise intensity (all P <.01; 
Figure 2). For the CV in running speed, significant changes were only 
observed between RPE11 and RPE13 (F(1,14) = 18.5, P  < .01, ηp2 
= .57) and RPE17 and RPE20 (F(1,14) = 14.1, P  < .01, ηp2 = 
.50; Table 3).
Significant Test main effects were observed for peak (F(2,28) = 4.35, 
P  < .05, ηp2 = .24), mean (F(1.4,19.4) = 7.88, P  < .01, ηp2 = .36) 
and end speed (F(2,28) = 6.05, P  < .01, ηp2 = .30), and distance 
ran (F(2,28) = 6.35, P  < .01, ηp2 = .31), with participants in SPV3 
running, on average, faster and further than both SPV1 and SPV2. 
Physiological response during SPV tests
A significant Test by RPE interaction was observed for HR (F(4.3, 60.1) 
= 4.19, P  < .05, ηp2 = .23),  
·VE (F(8,112) = 3.98, P  < .001, ηp2 
= .22) and RER (F(2.8,39.1) = 3.19, P  < .05, ηp2 = .19; Figure 3). 
During SPV1, participants experienced a greater change in HR,  ·VE 
and RER between RPE13 and RPE15 than either SPV2 or SPV3. 
RPE main effects were observed for  ·VO2, HR,  
·VE, RER and pain (all 
P <0.001; Figure 3). 
DISCUSSION 
This study assessed the validity and reproducibility of a field-based 
self-paced  ·VO2max test in recreationally-trained men. In this study, 
SPV1, SPV2 and SPV3 elicited similar  ·VO2max values to those ob-
tained from a traditional laboratory-based GXT. Accordingly, and in 
support of the study hypotheses, a field-based SPV test may be con-
FIG. 3. Mean (± SD) HR (3a), RER (3b), VO2 (3C) and VE (3d) at RPE 11, 13, 15, 17 and 20 for SPV1, SPV2 and SPV3
SPV1 SPV2 SPV3 Total
RPE 11 7.9 ± 5.9 4.8 ± 2.8 6.4 ± 4.2 6.4 ± 3.1*
RPE 13 2.9 ± 0.8 3.0 ± 1.7 2.9 ± 1.2 2.9 ± 1.1
RPE 15 3.3 ± 1.0 3.1 ± 1.6 2.3 ± 0.9 2.9 ± 0.8
RPE 17 4.1 ± 1.6 3.2 ± 1.5 2.9 ± 1.3 3.5 ± 1.1
RPE 20 8.7 ± 4.8 7.5 ± 5.4 7.7 ± 6.3 8.0 ± 5.0#
TABLE 3. The coefficient of variation (mean ± SD) for each 
perceptual intensity (RPE11, RPE13, RPE15, RPE17 & RPE20) 
and SPV test.
Note: *Significantly higher coefficient of variation than proceeding stage 
(RPE 13; P < .01), #Significantly higher coefficient of variation than 
preceding stage (RPE 17; P < .01).
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sidered a valid test of  ·VO2max, in keeping with previous laborato-
ry-based research [4-6]. Furthermore, the SPV test was considered 
reliable, as a period of trial familiarisation did not statistically mo-
derate the  ·VO2max or pacing response elicited. 
Despite no statistical differences and a high correlation (ICC: 
0.85-0.87) between the GXT and the three SPV tests, slightly hi-
gher  ·VO2max values were observed with the SPV (3.1%, 3.0% & 
4.8% for SPV1, SPV2 & SPV3, respectively), similar to past rese-
arch [1, 2, 5]. This is pertinent from a coach’s perspective as posi-
tive changes in aerobic capacity in the region of 3-5% have been ac-
cepted as a meaningful performance improvement [18, 19]. There-
fore, it is important to recognise: i) the practical implications of me-
asuring an athlete’s maximal aerobic capacity using differing methods 
of assessment, and ii) that the SPV may consistently elicit higher 
practical values than a laboratory-based GXT. However, it should be 
noted that near optimal environmental conditions were experienced 
in the course of the field data collection (e.g., wind speed ≤ 3 m·s-1) 
and thus, our findings should be considered in the context of this. 
Furthermore, as there appears to be a difference in  ·VO2max that is 
of practical significance, it is likely that the non-statistical difference 
in  ·VO2max between the GXT and SPV in the current study was due 
to the wide variance associated with the fitness level of the participants 
recruited (i.e., recreationally-trained). Future research should therefore 
ensure that participants are more closely matched for fitness when 
assessing the validity and reliability of the SPV protocol.
In this study, a mean difference in  ·VO2max of 0.05 mL·kg-1·min-1 
(0.2%) and 1.3 mL·kg-1·min-1 (1.8%) was observed between SPV1 
and SPV2, and SPV2 and SPV3, respectively. This is encouraging 
when considering that laboratory-based maximal exercise tests have 
shown a 3 to 6% variation in  ·VO2max values following three or more 
repeated trials [19, 20]. The reliability of the SPV protocol is further 
demonstrated using ICC (all >0.80), SEM and RC analyses for 
 ·VO2max and other variables of interest (Table 2). Accordingly, this 
study confirms that the application of a single SPV, which to date, 
has been the only way the test has been implemented previously [1-
6], may be appropriate for gauging  ·VO2max. However, as the ICC 
and RC’s were shown to improve with trial familiarisation (Table 2), 
and as  participants ran, on average, faster and further during SPV3 
than either SPV1 (4.3 & 3.1%, respectively) or SPV 2 (2.8 & 1.6%, 
respectively), there may be benefit in repeat assessments.
Despite the positive  ·VO2max findings, it is an athlete’s running 
speeds and pacing response at differing submaximal intensities that 
are perhaps more pertinent for training prescription. In this study, 
participants’ changes in speed (peak, mean and end speed) and 
distance between the five stages of the SPV protocol were similar 
between SPV1, SPV2 and SPV3 (see Figure 2). Although a more 
variable running speed was observed at the start (RPE11) and end 
(RPE20) of each SPV (Table 3), a similar overall pacing response 
was observed between the three trials. Each of the perceptual inten-
sities corresponded to 66-69% (RPE11), 69-73% (RPE13), 75-79% 
(RPE15) and 78-82% (RPE17) of the peak running speed observed 
from the  ·VO2max test. Knowledge of the speed, distance and heart 
rate responses at submaximal and maximal SPV stages may be a 
useful reference for coaches when determining and prescribing ap-
propriate training intensities, negating the need for expensive equip-
ment, designated laboratory facilities and trained technicians associ-
ated with traditional, maximal GXT protocols.
Regardless of the SPV test, the pacing response varied within SPV 
protocols. Although continuous increments in peak running speed 
were observed after RPE13, there were no differences in the peak 
running speed between RPE11 and RPE13 (Figure 2a). The mean 
speed and end speed for RPE11 was however lower than RPE13 
(Figure 2b & 2c), suggesting that participants adopted an inappropri-
ate starting speed (e.g. ran too fast) at the start of the protocol. In 
this regard, it is plausible that afferent feedback involving physiolog-
ical systems, environmental surroundings and psychological con-
structs (mood, self-efficacy, etc.) helped to adjust the pacing response 
after the initial peak speed was achieved to ensure that an appropri-
ate running speed was elicited thereafter. This appears to be cor-
roborated by the CV in running speed, which demonstrated a more 
variable pacing response at RPE11 compared to RPE13 (6.4 ± 3.1 
vs. 2.9 ± 1.1%, respectively). 
Knowledge of the exercise end-point has been suggested to be 
the single most important factor in influencing a pacing strategy [21]. 
In this study, a more conservative pacing strategy was observed 
during the latter portion (RPE15 & RPE17) of the SPV (Figure 2). 
This finding is complemented by the physiological data, as simi-
lar  ·VO2, HR,  
·VE and RER values were reported between RPE15 and 
RPE17 (Figure 3). The anticipated 2 min maximal sprint at RPE20 
may have encouraged participants to utilise a more conservative 
pacing strategy during the final moments of the penultimate stage of 
the exercise test. Similar findings have been shown else-
where [3,22,23]. For example, Sperlich et al. [23] demonstrated 
that when participants could manipulate both treadmill speed and 
inclination throughout a self-selected maximal exercise test, participants 
often elicited a rapid change in one or both of these factors in the final 
few minutes of the exercise test. In the present study, it is also of inter-
est to note that RPE20 elicited a greater CV in running speed than 
RPE17 (Table 3). The greater variation at RPE20 is likely due to the 
rapid increase and attempted maintenance of peak speed during this 
stage, stimulating a greater accumulation of metabolic by-products, 
and thus facilitating a greater perception of pain and discomfort than 
that associated with RPE17. Consequently, the SPV protocol may be 
better suited to experienced athletes as it may reflect the physiological 
and pacing demands encountered during competition. 
The researchers do recognise certain limitations to the study. In 
the present study, participants completed their laboratory-based GXT 
prior to any of the field-based SPV tests. To minimise the risk of any 
potential confounding effects associated with test order, it would have 
been useful to implement a randomised and counterbalanced cross-
over design. Our study also compared the physiological, physical and 
perceptual responses between treadmill and over-ground running. 
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As kinematic [24,25] and perceptual [26] differences may be evident 
between these ambulatory modalities, it may be speculated that 
these differences could have contributed to some of the statistical 
differences reported in Table 1. Similar to Hogg and colleagues [3], 
the lack of difference in peak running speed between the treadmill 
GXT and the field-based SPV may be due to limitations in achieving 
a ‘true’ peak running speed during treadmill exercise, which in-turn 
may confound the validity of the reported findings.
CONCLUSIONS 
This is the first study to demonstrate the concurrent validity and re-
liability of a field-based SPV. Measures of  ·VO2max in the field-based 
SPV were not statistically different from those in the laboratory-ba-
sed GXT, and trial familiarisation did not moderate the  ·VO2max va-
lues from the SPV. Thus, a single SPV test is considered appropria-
te for  ·VO2max assessment in the field. In addition, knowledge of the 
speed, distance and heart rate responses at submaximal and maxi-
mal SPV stages may provide useful points of reference for coaches 
when determining and prescribing appropriate training intensities, 
without the need for expensive equipment in the measurement of 
 ·VO2max. Future research should consider assessing the validity and 
reliability of the field-based SPV in participant groups of differing le-
vels of fitness.
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